Abstract
Cardiomyocytes are terminally differentiated cells that to date have been characterized as poor targets for nonviral gene transfer. This study was therefore designed to determine the optimal nonviral gene transfer parameters in cell cultures of neonatal rat cardiomyocytes and to compare them with the efficiency of gene transfer using adeno-associated viral vectors (AAV). Transfection efficiency was measured by quantitative chloramphenicol acetyltransferase type I (CAT)-enzyme-linked immunosorbent assay and β-galactosidase staining, based on overexpression of reporter genes (CAT and LacZ).
The efficiency of CAT/LacZ overexpression was assessed using the following techniques: (1) liposomal reagents, such as: FuGENE 6, LipofectAMINE 2000, LipofectAMINE PLUS, GenePORTER, Metafectene, and LipoGen; (2) electroporation and nucleofector techniques; and (3) an AAV2 vector harboring a lacZ reporter gene. Toxicity was monitored by total protein measurement and by analyzing cell metabolism.
On average, Lipofectamine 2000 was the most effective nonviral method examined yielding consistently high transfection rates (8.1% β-galactosidase-positive cells) combined with low toxicity. Electroporation also resulted in high transfection values (7.5%); however, cellular toxicity was higher than that of Lipofectamine 2000. Finally, transduction with AAV2 vectors provided the highest levels of transduction (88.1%) with no cellular toxicity.
We conclude that although transduction with AAV is more efficient (88.1%), transfections with nonviral techniques, when optimized, may provide a useful alternative for overexpression of therapeutic genes in neonatal cardiomyocytes.
Similar content being viewed by others
References
Felgner, P. L. (1991). Cationic liposome-mediated transfection with lipofectin reagent. In Gene Transfer and Expression Protocols, vol. 7, Methods in Molecular Biology (Murray, E. J., ed.), Humana Press, Clifton, NJ, pp. 81–89.
Blaese, R. M., Mullen, C. A., and Ramsey, W. J. (1993) Strategies for gene therapy. Pathol. Biol. (Paris) 41, 672–676.
Albert, N. and Tremblay, J. P. (1992) Evaluation of various gene transfection methods into human myoblast clones. Transplant Proc. 24, 2784–2786.
Dodds, E., Dunckley, M. G., Naujoks, K., Michaelis, U., and Dickson, G. (1998) Lipofection of cultured mouse muscle cells: a direct comparison of lipofectamine and DOSPER. Gene Ther. 5, 542–551.
Trivedi, R. A. and Dickson, G. (1995) Liposome-mediated gene transfer into normal and dystrophin-deficient mouse myoblasts. J. Neurochem. 64, 2230–2238.
Vitiello, L., Bockhold, K., Joshi P. B, and Worton, R. G. (1998) Transfection of cultured myoblasts in high serum concentration with DODAC:DOPE liposomes. Gene Ther. 5, 1306–1313.
Kott, M., Haberland, A., Zaitsev, S., Buchberger, B., Morano, I., and Bottger, M. (1998) A new efficient method for transfection of neonatal cardiomyocytes using histone H1 in combination with DOSPER liposomal transfection reagent. Somat. Cell Mol. Genet. 24, 257–261.
Aihara, H. and Miyazaki, J. (1998) Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16, 867–870.
Mir, L. M. (1999) High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. USA 96, 262–267.
Mathiesen, I. (1999) Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther. 6, 508–514.
Block T. A. (1995) Nonthermally mediated muscle injury and necrosis in electrical trauma. J. Burn Care Rehabil. 16, 581–588.
Lee, R. C., Canaday D. J., and Hammer, S. M. (1993) Transient and stable ionic permeabilization of isolated skeletal muscle cells after electrical shock. J. Burn Care Rehabil. 14, 528–540.
Green, N. K., Franklyn, J. A., Ohanian, V., Heagerty, A. M., and Gammage, M. D. (1997) Transfection of cardiac muscle: effects of overexpression of c-myc and c-fos proto-oncogene proteins in primary cultures of neonatal rat cardiac myocytes. Clin. Sci. (Lond.) 92, 181–188.
Monahan, P. E. and Samulski, R. J. (2000) Adeno-associated virus vectors for gene therapy: more pros than cons? Mol. Med. Today 6, 433–440.
Wollert, K. C., Taga, T., Saito, M., et al. (1996) Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy: assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J. Biol. Chem. 271, 9535–9545.
Davidson, B. L., Stein, C. S., Heth, J. A., et al. (2000) Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. USA 97, 3428–3432.
Brisson, M. and Huang, L. (1999) Liposomes: conquering the nuclear barrier. Curr. Opin. Mol. Ther. 1, 140–146.
Simoes, S., Pires, P., Duzgunes, N., and Pedrosa de Lima, M. C. (1999) Cationic liposomes as gene transfer vectors: barrier to successful application in gene therapy. Curr. Opin. Mol. Ther. 1, 147–157.
Clackson, T. (2000) Regulated gene expression systems. Gene Ther. 7, 120–125.
Cameron, J., Iversen, N., Torsdalen, K., Birkenes, B., and Djurovic, S. (2003) Electroporation is the best nonviral transfection technique in human endothelial and smooth muscle cells, submitted.
Bureau, M. F., Gehl, J., Deleuze, V., Mir, L. M., and Scherman, D. (2000) Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim. Biophys. Acta 1474, 353–359.
Vicat, J. M. (2000) Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression. Hum. Gene Ther. 11, 909–916.
Hoover, F. and Kalhovde, M. J. (2000) A double-in-jection DNA electroporation protocol to enhance in vivo gene delivery in skeletal muscle. Anal. Biochem. 285, 175–178.
Somia, N. and Verma, I. M. (2000) Gene therapy: trials and tribulations. Nat. Rev. Genet. 1, 91–99.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Djurovic, S., Iversen, N., Jeansson, S. et al. Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes. Mol Biotechnol 28, 21–31 (2004). https://doi.org/10.1385/MB:28:1:21
Issue Date:
DOI: https://doi.org/10.1385/MB:28:1:21